Perigord, innovators in Life Science Artwork Management Services and Solutions, and GlobalVision, leaders in the design and delivery of Innovative Proofreading Technologies, today announced their alliance for the integration of their artwork management systems in order to better service the Life Science Industries.
Perigord, recognising the value of working with GlobalVision, who have over 25 years’ experience in proofreading, has entered this strategic collaboration to enable seamless integration of GlobalVision’s Proofware software into their GLAMS (Global Artwork Management System) solution, resulting in streamlined exchanges and decreased time to market in the artwork processes.
Perigord’s GLAMS is a Configurable Off the Shelf (COTS) solution for Artwork Management that meets the current and future needs of Life Science customers. GlobalVision’s Proofware brings an advanced suite of application tools focused on delivering accuracy and traceability for Quality Control, reducing artwork rework cycles and cost. Through the integration of these software management systems, the user will benefit from quicker file comparisons during proofreading, improved quality control and earlier error detection. In addition, both systems facilitate 21 CFR Part 11 compliance to electronic records and electronic signature rules.
“We are excited to team with GlobalVision as they, like us, are specialists in the Life Science Industries and understand the GMP environment”, says Alan Leamy, CEO Perigord. “As one of our new partners, GlobalVision represent our belief that the future of artwork management through the lifecycle process requires integrated automated technologies as a necessity of providing accurate artwork to market, on time and right first time.”
Jonathan Hou, Director of Technology at GlobalVision, also comments: “At GlobalVision, we are looking forward to the synergy this strategic partnership can bring to current and future clients, and we recognize that Perigord’s business mission fits very well with that of our Life Science focus.”